Aoylated derivatives of 17cr-hydroxyprogesterone were prepared in order to test the hypothesis that dialkylamino alkyl moieties have the effect of transforming progestogens into antiprogestogens. This approach has been successful with certain estrogens. Compounds with other functional groups were synthesized to determine whether these might exert binding influence outside the area occupied by progesterone itself. The compounds were tested for competitive affinity against tritiated progesterone and receptor from rabbit uterus cytosol. The low affinity of all derivatives makes it unlikely that they would be active as antiprogestational agents.
S TDEOLDI
Attempts have been made to obtain derivatives of 17c+hydroprogester-one (17c+hydroxypregn-Lene-3,20-dione) which covalently bind to the receptor protein (1,2). These contained a very reactive diazoketone moiety. All four diazoketones synthesized in this series failed to alkylate the receptor protein, Initial efforts in this laboratory to synthesize antiprogestogens haveemployed the approach which successfully transformed estrogens into antiestrogens. Thus, the addition of a dialkylamino alkyl moiety to certain nonsteroidal estrogens provided antiestrogens such as clomiphene citrate, Such antiestrogens compete with estradiol for estrogenreceptor protein binding sites (3,lC,5) . The substituted amino moiety may bind to an anionic grouu inside or outside the site occupied by estradiol and thereby block interaction of the natural hormone with the receptor protein. It is known from structure-activity studies that it is possible to have full progestational activity in 17c+acyloxyproges-terone derivatives (6).
Some of these derivatives may exert binding influence outside the area occupied by progesterone itself. Incorporation of various functional groups in the 17a-acgl position might have the potential of reinforcing such binding to sites outside the progesterone binding site, and in analogy with antiestrogens, produce receptor blockade. e, Purified by column chromatography. This compound resisted recrystallization from customary solvents.
f. Purified by column chromatography. This comuopnd appeared to be unstable and satisfactory analysis could not be obtained. Spectral data (ir, nmr) supported the assigned structure and material appeared homogeneous on TLC.
g. Reported mp 112-U.4° (14) . h, Reported mp 173-1750 (14) .
S WDEOXDrn of the corresponding bromoacyloxy compounds with the apuropriate amine.
While progesterone and progesterone derivatives with a free 17~
hydroxyl have low receptor affinity, the esterification with fatty acids increases affinity markedly (8, 9, 10, 11) . Thus, the RA for acetate (I) and caproate were O.lC and 0.8, respectively, while the free hydroxy derivative was only 0.01 (11) . Addition of halogen in the acyl group reduces affinity markedly, the trifluoroacetate (II) being inactive. Increasing the chain length increases affinity despite the presence of halogen but even the bromocaproate ester (IX) (RA = O.lL7) is less active than the corresponding unsubstituted ester (FU = 0.80). It is doubtful whether these acyl groups at the 17cu-position actually contribute to binding, since these derivatives are all less potent than progesterone itself.
When basic side chains were introduced, there was a dramatic decrease in affinity (XT, XII, XIII). An ester function or a free carboxyl in the side chain was also very unfavorable, The benzoate (III) was inactive, probably for steric reasons, since the phenglacetates (IVa, b, VI) had significant receptor affinities. Again, introduction of a basic side-chain on the phenylacetate moiety (VI) led to inactivity.
These structure-affinity studies lead to the conclusion that the 17o-substituents project against a hydrophobic surface of the receptor protein and that any polar groups reduce affinity markedly. The low affinity of the substituted 17a-acyloxyprogesterones for progesterone receptor protein makes it unlikely that they would act as antiprogestational agents.
s wamoxxa-
EXPERIMENTAL SECTION
The procedures given in this section are representative for each of the analogous compounds presented in Table 1 . The melting points which are corrected, were taken on a Thomas-Hoover (capillary tube) apparatus. Analyses were performed by .Midwest Microlab, Ltd., Indianapolis, Ind. Ir spectra were obtained with a Perk5.n Elmer 337 spectrophotometer. (Me$.SI or DSS).
Nmr spectra were obtained with a A-60A spectrometer Method A -17a-Hydrowregn-lb-ene-3,20-dione 17-p-Iodophenylacetate Prepared according to the procedure of Solo and Gardner (1,2). (IVb).
Method B -17o!-Hydroxypregn-lcene-3,20-dione 17-(5-Bromopentanoate) (IX). A solution of ptoluenesulfonic acid (200 mg) in dry benzene (2f,ml) was heated to gentle reflux and moisture removed with the aid of Dean-Stark water separator for 1 hr. 17o-Hydroxyprogesterone (200 mg) was added to the cooled solution followed by 5-bromopentanoic anhydride (The anhydrides were prepared by the procedure of Diczfalusy et al. (12) .) (0.9 gm) dissolved in dry benzene (5 ml). The clear --solution was then allowed to stand at room temperature for 2 days. After this period, the solution was poured into cold H $ 0 (50 ml) and the mixture stirred for several hours. It was then ex ratted into ether. The combined ether extracts were washed successively with H20, dilute HCl solution, 5$ NaHCO organic phase was dried (Na2S 8 soln, and saturated NaCl soln. The 4) and the solvent completely removed under reduced pressure, The resulting oily residue was chromatographed over alumina. Elution with ethyl acetate and subsequent crystallization from aq. acetone afforded IX as colorless crystals.
Method C -17cu-Hydroxypregn-4-ene-3,20-dione 17-p-(2-Pyrrolidinethoxy)-yhenylacetate Hydrochloride (VI). A solution containing V (400 mg) and a few crystals of KI in freshly distilled pyrrolidine (10 nil) was heated to gentle reflux with stirring for 2 days. Pyrrolidine was then removed under vacuum and residue was triturated with "20 when solid separated. It was collected on filter and washed well with H2C. Ir spectrum of this residue indicated formation of enamine, therefore, this solid was dissolved in 9% ethanol (20 ml) and heated to gentle reflux for 1.5 hr. After this period, solvent ethanol was completely removed under vacuum and residue treated with H20. It was then collected on a filter, dried and dissolved in dry ether, Addition of ethanol& HCl precipitated HCl salt which was collected and recrystallized from ethanol-petroleum ether (300-600) to afford VI as white solid. Competitive binding assay for vrogestogen-receptor affinity. Each substance was tested for competitive affinity against tritium-labelled progesterone-3H (57 Ci/mmol, New England Nuclear, Boston, Mass.) and receptor from rabbit uterus cytosol (11) . A series of test tubes were prevared with 0.5 ml buffer (lO$ glycerol in 0.01 PI Tris, 1Jr 7.4, with 0..0015 M EDTA and 0.25 M sucrose). The avprouriate amounts of unlabelled comvetitors and labelled progesterone (3x10-10 M) were dissolved in this buffer and 25 ~1 of uterine cytosol was added. The tubes were incubated for 16-18 hours at +4oC:. 3H-Progesterone binding was measured by charcoal absorntion. Every substance was run in at least 4 different concentrations in 3-fold dilution steps. A_;tpdard cur e with unlabelled progesterone, concentrations between 10 -10 -8 M, was run at each experimental occasion. All substances were assayed at least twice. The percentage inhibition was plotted against log concentration of competitor and the voint of $$ competition was used for potency comparison. In Table 1 , the competitive potencies on a molar basis are given relative to progesterone (= 1).
